Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - Academy

Academy

A. Marchant - S. Goriely - N. Dauby - S. De Wit - O. Vandenbergh - C. Montesino - V. Mascart - V. Del Marmol - A. Le Moine - F. Andris - C. Gueydan - A. Botteaux - A. Matagne

ULB, CHU Saint-Pierre, Hôpital Erasme, ULiège - FNRS

" The project investigates the immune responses to SARS-CoV-2 infection in humans. Cohorts of patients and contacts are recruited and followed-up during several months following infection. Using systems serology and systems biology approaches, the quality and dynamics of antibody and cellular responses are analysed to identify correlates of protection against severe disease and to determine the duration of natural immunity to the virus. The project should provide insight in the host response to SARS-CoV-2 and should help define deconfinement strategies and develop prophylactic and therapeutic interventions against COVID-19. "
Funding: COVID 19 - ULB
Contact: Arnaud Marchant: This email address is being protected from spambots. You need JavaScript enabled to view it. Stanislas Goriely: This email address is being protected from spambots. You need JavaScript enabled to view it.

André Matagne, Alain Brans, Marylène Vandevenne, Maximiliano Figueroa, Moreno Galleni, Romain Malempré

ULiège - Royal Academy of Sciences, Letters and Fine Arts of Belgium
"The Centre for Protein Engineering (CIP, ULiège), through its two technological platforms, has been involved in the production of reagents (i.e. proteins) for diagnostic and analyses of SARSCoV-2 infection. In particular, Protein Factory has produced a pure and highly active enzyme (CAS12) for a CRISPR/CAS assay, which, in combination with classical PCR technology allows rapid detection of the virus. Automated screening is currently performed at Robotein for optimal formulation of CAS12. The production of complementary protein reagents for such tests is underway. Furthermore, in a collaborative effort with Dr Arnaud Marchant at Institut d'Immunologie Médicale (ULB), the CIP is involved in the design and production of recombinant SARS-COV-2 antigens towards the development of a platform for high dimensional systems serology analysis of SARS-CoV-2 antibodies."
Contact: André Matagne This email address is being protected from spambots. You need JavaScript enabled to view it. 

Claude Tomberg, Professor - Sophie Pellon, PHD Student - Claire Drogoz-Villegas, Clinical psychologist

ULB - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" Our study aims to investigate the impact on mental health and well-being of the people during the containment due to COVID-19 pandemic. More specifically some factors are analyzed such as animal ownership and the practice of artistic activities. An online survey was developped including validated psychological scales. "
Funding: Fondation Prince Laurent
Publication References: The results are currently under statistical analysis
Contact : Claude TOMBERG: This email address is being protected from spambots. You need JavaScript enabled to view it. Sophie PELLON : This email address is being protected from spambots. You need JavaScript enabled to view it. Claire Drogoz-Villegas : This email address is being protected from spambots. You need JavaScript enabled to view it. http://cognit.ulb.be/wordpress/ 
Comment: This research has been accepted by the Ethics committee Erasme Hospital (April 17, 2020)

Isabelle Salmon, Professor

ULB, Department of Pathology, Erasme hospital and DIAPath-CMMI - Royal Academy of Medicine of Belgium
" A first objective of this project is to establish an accurate topography of the SARS-CoV-2 virus in the organs and various cells of patients who died in COVID-19 units, in order to contribute to a better understanding of the pathogenesis of COVID-19. A second objective is to provide a routine diagnostic test for the detection of SARS-CoV-2 in routine samples in pathological anatomy. "
Funding: Fonds Y Boël (Brussels, Belgium), Fonds Erasme pour la Recherche Médicale (Brussels, Belgium), and "Appel à projet Spécial COVID-19 - ULB" (Brussels, Belgium). The CMMI is supported by the European Regional Development Fund and the Walloon Region of Belgium (Wallonia-biomed; grant no. 411132-957270; project "CMMI-ULB").
Contact: Prof. I. Salmon, Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Route de Lennik 808, 1070 Brussels, Belgium.

Jean-Francois Collet, Professor

UCLouvain - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" Optimisation of bacterial strains for the expression of proteins from the COVID-19 virus Optimisation of bacterial strains for the expression of proteins from the COVID-19 virus Optimisation of bacterial strains for the expression of proteins from the COVID-19 virus "
Funding: FNRS
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Jean-Luc Belche, Chargé de cours

ULiège - Royal Academy of Medicine of Belgium
" Analysis, in Brussels and Wallonia, of creation, daily management, and use of triage COVID-19 centers as well as satisfaction, suggestions of personnel working in these centers in order to develop a model for further crisis. "
Funding: FNRS: Urgent research credit submitted Possible extension to Flanders.
Publication References: Belche JL, Berrewaerts MA, Burette P, Lenoir AL, Duchesnes C, Giet D. Retrospective analysis of a suburban out-of-hours clinic in Belgium. Acta Clinica Belgica 2014, 69(5):341-347. Buret L, Duchesnes C, Giet D. Des dispositifs d'intégration clinique pour les situations complexes : aide fonctionnelle et défi normatif. Presse Médicale 2017, 46(11) :1113-1114.
Contact: JeanLuc BELCHE. Département de Médecine générale, Université de Liège. This email address is being protected from spambots. You need JavaScript enabled to view it.
Comment: Promoteur : JeanLuc BELCHE Investigateur principal : Louise Joly Chercheurs associés : Béatrice Scholtès, Christiane Duchesnes Etudiante en médecine...

Jean-Paul Coutelier, FNRS Research Director, Professor

UCLouvain - FNRS
" In collaboration with the University of Rwanda, pro-inflammatory and anti-inflammatory cytokines will be measured in the plasma of COVID-19 patients and their level will be correlated with the severity of the disease. "
Funding: ARES-CCD
Publication References: Ndoricyimpaye EL, Tuyishimire J, Vanwambeke S, Mutesa L, Nyandwi E, Rujeni N, Coutelier J-P. L'épidémie de SARS-CoV-2 en Afrique sub-Saharienne, questions, craintes et espoirs. Louvain Médical, submitted.
Contact: Prof. J.-P. Coutelier de Duve Institute Universite Catholique de Louvain SSS/DDUV - ICP Av. Hippocrate 75, bte B1.74.05 1200 Woluwe-Saint-Lambert, Belgique tel 32 2 764 7437 fax 32 2 764 7430 e-mail This email address is being protected from spambots. You need JavaScript enabled to view it.

Luc Willems, FNRS Research Director

ULiège - FNRS - Royal Academy of Medicine of Belgium
" Massive infiltration of activated macrophages is associated with the development of a cytokine storm that leads to severe acute respiratory syndrome induced by SARS-CoV-2. Based on our results demonstrating the key role exerted by epigenetic regulation in the activity of macrophages, we propose to study the methyltransferase EZH2 in the pathogenesis induced by SARS-CoV-2. We have also shown that the PD-1 immune checkpoint is responsible for the macrophage anergy induced by the absence of EZH2. The goal of the project is to temper the excessive inflammatory responses associated with macrophages by interfering on the EZH2-PD-1 axis. "
Funding: Decision pending (FNRS Crédit Urgent de Recherche 40002642)
Publication References: - Inhibition of EZH2 methyltransferase decreases immunoediting of mesothelioma cells by autologous macrophages through a PD-1-dependent mechanism. Malik Hamaidia, Hélène Gazon, Clotilde Hoyos, Gabriela...

Mostafa Chamekh, Professor (coordinator of the project) - Georges Casimir, Professor - Francis Corazza, Professor- David de Bels, Doctor

ULB - Royal Academy of Medicine of Belgium
" The project aims at understanding why men are more affected than women. Compelling evidences indicate sex-bias in SARS-CoV2 with male representing the majority of severe cases requiring intensive care. Excessive inflammatory symptoms attributed mainly to cytokine storm is the hall-mark of disease progress. We ask whether differences in genetic fitness between male and female patients could contribute to sex-bias and we focus, in particular, on potential role of microRNAs in fine tuning the type and magnitude of the inflammatory response "
Funding: Current application to FNRS IRIS research
Publication References: - Chamekh M, M Deny, M Romano, et al. Differential Susceptibility to Infectious Respiratory Diseases between Males and Females Linked to Sex-Specific Innate Immune Inflammatory Response. Front Immunol. 2017; 8: 1806. - Casimir, G. J., Lefèvre, N., Corazza, F et al. J. Sex and inflammation in respiratory diseases : a clinical...

O. Vandenberg, Pr. - N. Clumeck, Pr. - C. Montesinos, Pr. - N. Dauby, MD, PhD - C. Gilles, MD - C. Martin, MD - S. Van den Wijngaert, MD - A. Marchant, Pr. - D. Martiny, Pr. - S. De Wit, Pr.

LHUB-ULB - Royal Academy of Medicine of Belgium
" "The purpose of this study is to map the healthcare workers exposure risk in Saint-Pierre University Hospital by combining molecular methods with serological assays. In summary, the short-term objective is threefold: (1) Provide an estimate of the sero-prevalence at baseline among high-risk health care workers (2) Determine prospectively the incidence of new SARS-CoV-2 infections among high-risk health care workers (3) Estimate the healthcare worker exposure to the virus by serological data to help our five partner hospitals in their day-to-day management of the ongoing pandemic The mid-term objectives are: (1) Establish an accurate mapping of the spread of the virus among our population allowing to identify the chain of transmission, (2) Identify predictive immunological markers of susceptibility to infection and disease severity to inform vaccine strategies and, (3) Establish solid diagnosis algorithm that will help adequate lockdown...

Ph. DELVENNE, FNRS Research Director / Chef de service Anatomie pathologique - J. GUIOT, Chef de clinique Pneumologie - L. RENAUD, Chef de service Pneumologie - M. MOUTSCHEN, Chef de service Infectiologie- B. MISSET, Chef de service Soins Intensifs

ULiège, CHU - Royal Academy of Medicine of Belgium
" Nous faisons face à une pandémie d'infection COVID-19. Ce virus pathogène est source de complications pulmonaires aggravant fortement le pronostic de nos patients. De nos jours, tant les mécanismes physiopathologiques en cause que les marqueurs de sévérité de l'atteinte restent indéterminés. Il apparaît donc comme urgent de pouvoir identifier des marqueurs diagnostiques, pronostiques et prédictifs pour nos patients. Dans ce contexte, plusieurs voies rapidement explorables nous apparaissent comme critiques. Le but final de cette étude est de contribuer à une prise en charge plus ciblée des patients porteurs d'une infection au SRAS-Cov-2. "
Funding: Fonds Léon Frederic
Publication References: Dix publications représentatives : 1) Prevention of murine radiogenic thymic lymphomas by tumor necrosis factor or by marrow grafting. HUMBLET C, GREIMERS R, DELVENNE P, DEMAN J, BONIVER J, DEFRESNE MP. J Natl Cancer Inst 88 (1996), 824-831. IF...

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Philippe Denoel, Head of External R&D

GSK - Royal Academy of Medicine of Belgium
" Support covid international: https://www.gsk.com/en-gb/media/resource-centre/our-contribution-to-the-fight-against-2019-ncov/ Support covid en Belgique: https://be.gsk.com/media/915368/cp-gsk-contributions-majeures-de-gsk-a-la-lutte-contre-le-covid-19.pdf NA NA "
Funding: NA
Contact: Philippe Denoel - This email address is being protected from spambots. You need JavaScript enabled to view it.

Philippe PEIGNEUX, Professor - Peter SIMOR, Postdoc IF-ULB - Rebeca SIFUENTES, Aspirant FNRS - Ariadna ALBAJARA SAENZ, postdoctoral researcher

ULB, UR2NF - Neuropsychology and Functional Neuroimaging Research Unit affiliated at CRCN - Center for Research in Cognition and Neurosciences and UNI - ULB Neurosciences Institute - FNRS - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" The aim of the study is to examine day-to-day associations between subjective sleep quality and daytime functioning during the large-scale confinement measures taken in Belgium given the current Covid-19 pandemic in Europe. In particular, we are interested in assessing the interplay between altered patterns of sleep timing, duration and quality, and daytime behaviour, cognition, and affect for 2 weeks during the confinement period. Longitudinal data are obtained in Belgium, Hungary and Spain "
Funding: internal resources
Publication References: ongoing project
Contact: Project : This email address is being protected from spambots. You need JavaScript enabled to view it., Peter Simor: This email address is being protected from spambots. You need JavaScript enabled to view it. Philippe Peigneux : This email address is being protected from spambots. You need JavaScript enabled to view it.

Serge Goldman, Scientific Director

CMMI
" The Center of Microscopy and Molecular Imaging (CMMI) is currently involved in establishing an accurate SARS-CoV-2 virus distribution topography in the organs and various cells of patients who died in COVID-19 units by providing immunohistochemistry and electron microscopy services (study director Pr. Isabelle Salmon). We have also developed and are currently offering preclinical multimodal quantitative imaging - of lung inflammation - of bacterial population (pathogen or no pathogen) - and of viral infection by isotopic imaging. All these models enable the understanding of pulmonary pathological features caused by SARS-viruses such as CoVID-19. From molecular to humanized animal models, the CMMI provides customized imaging solutions to research projects on Coronavirus The CMMI is also a proud partner of the ULB diagnostic platform set-up in Gosselies to face the epidemic of SARS-CoV2. "
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
Comment: The CMMI was co-founded by ULB et UMons and is supported...

Souad Rahmouni, Doctor

GIGA-Institute, ULiège - FNRS - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" The main objective of our research program is the identification of human genetic factors impacting the COVID19 pandemic. Within the COVID-19 host genetics initiative (https://www.covid19hg.org/), we will establish a shared set of phenotypes to be combined with genomic data for standard GWAS and further meta-analysis. Field of expertise of our laboratory : genetics, genomics, bioinformatics, immune-response related diseases. In addition, the GIGA Institute is an interdisciplinary research institute from the ULiege devoted to academic excellence in the biomedical sciences to foster ground-breaking medical innovation. It comprises 583 members attached to six faculties (Medicine, Science, Veterinary Medicine, Engineering, Agbiotech, Psychology) that are organized in four disease-based (neuroscience, cancer, infection-inflammation-immunity, cardiovascular) and two method-based thematic units...

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

info@COVID19-WB.be

Brussels & Wallonia against COVID19